Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting

Published:2019-06-17 Issue:2 Volume:103 Page:116-123
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Ito Tomoki¹^ORCID,Hashimoto Yoshinori²^ORCID,Tanaka Yasuhiro³,Nakaya Aya¹^ORCID,Fujita Shinya¹,Satake Atsushi¹,Nakanishi Takahisa¹,Konishi Akiko¹,Hotta Masaaki¹,Yoshimura Hideaki¹,Ishii Kazuyoshi¹,Hashimoto Akiko³,Kondo Toshinori⁴,Omura Hiromi²,Shinzato Isaku³,Tanaka Takayuki²,Nomura Shosaku¹

Affiliation:

1. First Department of Internal Medicine Kansai Medical University Hirakata Japan

2. Department of Hematology Tottori Prefectural Central Hospital Tottori Japan

3. Department of Hematology and Clinical Immunology Kobe City Nishi‐Kobe Medical Center Kobe Japan

4. Department of Hematology Kawasaki Medical School Kurashiki Japan

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13265

Reference34 articles.

1. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

2. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

3. NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018

4. JSH guideline for tumors of hematopoietic and lymphoid tissues—lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN)

5. Inhibition of platelet production induced by an antiplatelet drug, anagrelide, in normal volunteers;Abe Andes W;Thromb Haemost,1984

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial Low-Dose Hydroxyurea and Anagrelide Combination in Essential Thrombocythemia: Comparable Response with Lower Toxicity;Journal of Clinical Medicine;2024-05-14

2. Essential thrombocythaemia: A contemporary approach with new drugs on the horizon;British Journal of Haematology;2024-04-08

3. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group;Clinical and Experimental Medicine;2023-09-25

4. BCR::ABL1 negative myeloproliferative neoplasms: A review focused on essential thrombocythemia and polycythemia vera;Physiology International;2023-09-05

5. A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment;Frontiers in Oncology;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3